June 23, 2016

Paul McKenzie joined Biogen in February from Johnson & Johnson, where had most recently been J&J’s VP research and development for its Ethicon business. 

June 23, 2016

ACIP continues to recommend annual flu vaccination, with either the inactivated influenza vaccine or recombinant influenza vaccine, for everyone 6 months and older.

June 23, 2016

Specifically, CMS' proposed guidance would standardize the reporting by PDP sponsors of price concessions received from, and incentive payments made to, participating network pharmacies.

June 23, 2016

Nonalcoholic steatohepatitis (NASH), a fatty liver disease, affects about 2% to 5% of the U.S. population and doesn't currently have an approved treatment. 

June 22, 2016

Headquartered in New York, Snow Phipps has overseen the deployment of over $1.7 billion of private equity capital and co-investments in 17 platform investments and over 25 add-on acquisitions since inception.

June 22, 2016

The bill was met with praise from several industry groups when it was introduced, and a Generic Pharmaceutical Association member testified at the hearing. 

June 22, 2016

Taro noted that Kalb’s departure was not the result of a dispute or disagreement with the company, including anything having to do with its accounting practices or financial reporting. 

June 21, 2016
The company expects Rayaldee to be available in the second half of 2016. 
June 20, 2016

The authors found that increased adoption rates followed states allowing pharmacists to administer the vaccine.

June 15, 2016

The pilot program, which in effect would allow the DoD to access lower pricing for prescriptions dispensed at community pharmacies, is included in the version of the NDAA passed by the House on May 18, but not in the version passed by the Senate June 14.

June 14, 2016

Gonitro is indicated to prevent or provide acute relief for an attack of angina pectoris due to coronary artery disease and it is available in single-dose packets of a short-acting nitrate in a stabilized crystal granule form. 

June 14, 2016

Since 1959 the DIANA awards have honored HDA-member manufacturers that develop innovative new product introductions and promotions for the healthcare distribution industry.

June 13, 2016

The peak percentage of outpatient visits for ILI was 3.6% and occurred during the week ending March 12, 2016.

June 13, 2016

The vaccine — the first FDA-approved cholera prevention vaccine — is aimed at travelers headed to countries with inadequate water and sewage treatment and poor sanitation.

June 13, 2016

Incorporating the word “Alliance” into the association's new brand, in particular, reflects HDA's role as a convener of the supply chain — in the United States and now abroad, HDA stated. 

June 10, 2016

Upsher-Smith’s Qudexy XR has gained tentative approval from the Food and Drug Administration as a preventative therapy for migraine headaches.

June 10, 2016

The new weight limit for the 10- and 25-mg oral tablets is now at least 30 kg, down from at least 40 kg for patients aged 6 to less than 12 years. 

June 8, 2016
The program, RespiPoints, is being undertaken in partnership with HealthPrize Technologies. 
June 7, 2016

Under the partnership, Ultragenyx will initially receive an exclusive license for one of Takeda’s preclinical product candidates in a pre-determined field of use, along with the option to co-develop and co-commercialize the candidate in other therapeutic areas.

June 6, 2016

The drug is indicated to treat hypertension to lower blood pressure, and the company said it is the first fixed-dose combination of a beta-blocker and an angiotensin II receptor blocker in the U.S.

June 1, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of pharmacy technology, in this multi-page report.

June 1, 2016
The topical steroid is indicated to treat mild to moderate plaque psoriasis in patients older than 18 years of age. 
 
June 1, 2016
The trade name of the drug was initially Brintellix when it was approved in September 2013 and FDA approved a name change to minimize patient confusion over similarly named medication in early May. 
May 31, 2016

Zinbryta is a once-daily self-administered injection indicated to treat relapsing forms of multiple sclerosis in patients who have had an inadequate response to two or more MS therapies.